BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 32331428)

  • 1. Lysophosphatidylcholine Containing Anisic Acid Is Able to Stimulate Insulin Secretion Targeting G Protein Coupled Receptors.
    Drzazga A; Okulus M; Rychlicka M; Biegała Ł; Gliszczyńska A; Gendaszewska-Darmach E
    Nutrients; 2020 Apr; 12(4):. PubMed ID: 32331428
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Isoprenoid Derivatives of Lysophosphatidylcholines Enhance Insulin and GLP-1 Secretion through Lipid-Binding GPCRs.
    Drzazga A; Kamińska D; Gliszczyńska A; Gendaszewska-Darmach E
    Int J Mol Sci; 2021 May; 22(11):. PubMed ID: 34072220
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lysophosphatidylcholine and its phosphorothioate analogues potentiate insulin secretion via GPR40 (FFAR1), GPR55 and GPR119 receptors in a different manner.
    Drzazga A; Kristinsson H; Sałaga M; Zatorski H; Koziołkiewicz M; Gendaszewska-Darmach E; Bergsten P
    Mol Cell Endocrinol; 2018 Sep; 472():117-125. PubMed ID: 29225068
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Formation of βTC3 and MIN6 Pseudoislets Changes the Expression Pattern of Gpr40, Gpr55, and Gpr119 Receptors and Improves Lysophosphatidylcholines-Potentiated Glucose-Stimulated Insulin Secretion.
    Drzazga A; Cichońska E; Koziołkiewicz M; Gendaszewska-Darmach E
    Cells; 2020 Sep; 9(9):. PubMed ID: 32917053
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 2-OMe-lysophosphatidylcholine analogues are GPR119 ligands and activate insulin secretion from βTC-3 pancreatic cells: Evaluation of structure-dependent biological activity.
    Drzazga A; Sowińska A; Krzemińska A; Okruszek A; Paneth P; Koziołkiewicz M; Gendaszewska-Darmach E
    Biochim Biophys Acta Mol Cell Biol Lipids; 2018 Jan; 1863(1):91-103. PubMed ID: 29079451
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lysophosphatidylcholine enhances glucose-dependent insulin secretion via an orphan G-protein-coupled receptor.
    Soga T; Ohishi T; Matsui T; Saito T; Matsumoto M; Takasaki J; Matsumoto S; Kamohara M; Hiyama H; Yoshida S; Momose K; Ueda Y; Matsushime H; Kobori M; Furuichi K
    Biochem Biophys Res Commun; 2005 Jan; 326(4):744-51. PubMed ID: 15607732
    [TBL] [Abstract][Full Text] [Related]  

  • 7. G-protein coupled receptor 55 agonists increase insulin secretion through inositol trisphosphate-mediated calcium release in pancreatic β-cells.
    Vong CT; Tseng HHL; Kwan YW; Lee SM; Hoi MPM
    Eur J Pharmacol; 2019 Jul; 854():372-379. PubMed ID: 31054273
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacological regulation of insulin secretion in MIN6 cells through the fatty acid receptor GPR40: identification of agonist and antagonist small molecules.
    Briscoe CP; Peat AJ; McKeown SC; Corbett DF; Goetz AS; Littleton TR; McCoy DC; Kenakin TP; Andrews JL; Ammala C; Fornwald JA; Ignar DM; Jenkinson S
    Br J Pharmacol; 2006 Jul; 148(5):619-28. PubMed ID: 16702987
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sulfur- and acyl chain-dependent influence of 2-methoxy-lysophosphatidylcholine analogues on β pancreatic cells.
    Drzazga A; Ciesielska A; Gendaszewska-Darmach E
    Curr Top Med Chem; 2015; 15(23):2395-405. PubMed ID: 26088355
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Discovery and characterization of novel small molecule agonists of G protein-coupled receptor 119.
    Zhang SY; Li J; Xie X
    Acta Pharmacol Sin; 2014 Apr; 35(4):540-8. PubMed ID: 24681896
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of a novel GPR119 agonist, AS1269574, with in vitro and in vivo glucose-stimulated insulin secretion.
    Yoshida S; Ohishi T; Matsui T; Shibasaki M
    Biochem Biophys Res Commun; 2010 Sep; 400(3):437-41. PubMed ID: 20804735
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alteration of the glucagon axis in GPR120 (FFAR4) knockout mice: a role for GPR120 in glucagon secretion.
    Suckow AT; Polidori D; Yan W; Chon S; Ma JY; Leonard J; Briscoe CP
    J Biol Chem; 2014 May; 289(22):15751-63. PubMed ID: 24742677
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Potentiation of Glucose-stimulated Insulin Secretion by the GPR40-PLC-TRPC Pathway in Pancreatic β-Cells.
    Yamada H; Yoshida M; Ito K; Dezaki K; Yada T; Ishikawa SE; Kakei M
    Sci Rep; 2016 May; 6():25912. PubMed ID: 27180622
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Free fatty acids increase cytosolic free calcium and stimulate insulin secretion from beta-cells through activation of GPR40.
    Schnell S; Schaefer M; Schöfl C
    Mol Cell Endocrinol; 2007 Jan; 263(1-2):173-80. PubMed ID: 17101212
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of the insulin releasing and antihyperglycaemic activities of GPR55 lipid agonists using clonal beta-cells, isolated pancreatic islets and mice.
    McKillop AM; Moran BM; Abdel-Wahab YH; Flatt PR
    Br J Pharmacol; 2013 Nov; 170(5):978-90. PubMed ID: 23992544
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Agonists at GPR119 mediate secretion of GLP-1 from mouse enteroendocrine cells through glucose-independent pathways.
    Lan H; Lin HV; Wang CF; Wright MJ; Xu S; Kang L; Juhl K; Hedrick JA; Kowalski TJ
    Br J Pharmacol; 2012 Apr; 165(8):2799-807. PubMed ID: 22029751
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The fatty acid receptor GPR40 plays a role in insulin secretion in vivo after high-fat feeding.
    Kebede M; Alquier T; Latour MG; Semache M; Tremblay C; Poitout V
    Diabetes; 2008 Sep; 57(9):2432-7. PubMed ID: 18559658
    [TBL] [Abstract][Full Text] [Related]  

  • 18. DS-8500a, an Orally Available G Protein-Coupled Receptor 119 Agonist, Upregulates Glucagon-Like Peptide-1 and Enhances Glucose-Dependent Insulin Secretion and Improves Glucose Homeostasis in Type 2 Diabetic Rats.
    Matsumoto K; Yoshitomi T; Ishimoto Y; Tanaka N; Takahashi K; Watanabe A; Chiba K
    J Pharmacol Exp Ther; 2018 Dec; 367(3):509-517. PubMed ID: 30217957
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased glucose metabolism and glycerolipid formation by fatty acids and GPR40 receptor signaling underlies the fatty acid potentiation of insulin secretion.
    El-Azzouny M; Evans CR; Treutelaar MK; Kennedy RT; Burant CF
    J Biol Chem; 2014 May; 289(19):13575-88. PubMed ID: 24675078
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The relationship between GPR40 and lipotoxicity of the pancreatic β-cells as well as the effect of pioglitazone.
    Wu P; Yang L; Shen X
    Biochem Biophys Res Commun; 2010 Dec; 403(1):36-9. PubMed ID: 21036144
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.